D.E. Shaw & Co
GRTS

D.E. Shaw & Co’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

D.E. Shaw & Co’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,273
Closed -$42K – 5880
2022
Q1 		$42K Sell
10,273
-337,638
-97% -$1.79M ﹤0.01% 5183
2021
Q4 		$4.47M Sell
347,911
-971,882
-74% -$10.8M ﹤0.01% 2502
2021
Q3 		$14.3M Buy
1,319,793
+65,073
+5% +$592K 0.01% 1244
2021
Q2 		$11.5M Buy
1,254,720
+714,922
+132% +$6.61M 0.01% 1380
2021
Q1 		$5.09M Buy
539,798
+333,436
+162% +$4.59M ﹤0.01% 1830
2020
Q4 		$813K Buy
206,362
+27,195
+15% +$82.2K ﹤0.01% 3159
2020
Q3 		$475K Buy
+179,167
New +$665K ﹤0.01% 3256
2019
Q1 		– Sell
-10,130
Closed -$157K – 3998
2018
Q4 		$157K Buy
+10,130
New +$193K ﹤0.01% 3589

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

D.E. Shaw & Co's GRTS Position: Q2 2022 in Review

D.E. Shaw & Co sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2022, closing a stake of 10,273 shares — an estimated $42K sold.

D.E. Shaw & Co first reported a position in GRTS in Q4 2018 and held it in 8 quarters. The position peaked at $14.3M in Q3 2021. 87 funds tracked by Wall St. Rank hold GRTS as of Q2 2022.

  • D.E. Shaw & Co reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 10,273 Gritstone bio, Inc. Common Stock shares in Q2 2022, an estimated $42K.
  • D.E. Shaw & Co first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 8 quarters.
  • D.E. Shaw & Co's Gritstone bio, Inc. Common Stock position peaked at $14.3M in Q3 2021.
  • 87 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.